VP Antibody Development
Cardiff, UK - Hybrid
Antiverse are building something genuinely different in AI-driven antibody drug discovery, and this is a key scientific leadership hire at the centre of it.
They’re looking for a VP of Antibody Development to take ownership of how programmes move from discovery through in vivo and into partner-ready assets, with a clear path through to CSO.
This is a role for someone who wants real scientific influence, not just oversight.
What you’ll actually be doing
- Owning progression of internal and partnered programmes from hit through to in vivo validation
- Defining and prioritising pipeline strategy, making clear, data-driven decisions
- Designing and overseeing in vivo studies, working closely with CROs
- Translating in vitro data into strong in vivo hypotheses
- Driving optimisation to ensure assets are genuinely ready for downstream development and partnering
- Managing CROs across timelines, budgets and quality
- Working closely with leadership on broader scientific strategy
- Acting as a key external face of the science, with partners, investors and the wider network
- Playing a big part in building out the team over time
What they need
- 12–20+ years in antibody therapeutics or biologics R&D
- PhD in a relevant field
- Proven track record of progressing programmes
- Strong experience working with and managing CROs
- Comfortable in a fast-moving, early-stage environment
- Someone who wants to step into a bigger leadership role over time
Why it’s worth a conversation
You’re not just running programmes here, you’re shaping how the pipeline is built and progressed. There’s proper ownership, direct input into strategy, and a clear route into a CSO position.
If you want to be closer to the science and still have real influence on direction, this is a strong opportunity.